[go: up one dir, main page]

MX2016013584A - Parvovirus porcino. - Google Patents

Parvovirus porcino.

Info

Publication number
MX2016013584A
MX2016013584A MX2016013584A MX2016013584A MX2016013584A MX 2016013584 A MX2016013584 A MX 2016013584A MX 2016013584 A MX2016013584 A MX 2016013584A MX 2016013584 A MX2016013584 A MX 2016013584A MX 2016013584 A MX2016013584 A MX 2016013584A
Authority
MX
Mexico
Prior art keywords
virus
porcine parvovirus
relates
proteins
novel
Prior art date
Application number
MX2016013584A
Other languages
English (en)
Other versions
MX383506B (es
Inventor
Carla Christina Schrier
GUELEN Lars
Groof Ad
Deijs Martin
Maria Hoek Van Der Cornelia
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2016013584A publication Critical patent/MX2016013584A/es
Publication of MX383506B publication Critical patent/MX383506B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

La presente invención está relacionada con un parvovirus porcino novedoso, con proteínas del virus y con vacunas basadas en el virus y proteínas del mismo; la invención también está relacionada con fragmentos de ADN que comprenden un gen del virus y con vacunas de ADN basadas en los genes del virus; además, la invención se refiere a anticuerpos que son reactivos con el virus novedoso y a pruebas de diagnóstico para la detección del virus o de anticuerpos contra el virus.
MX2016013584A 2014-04-17 2015-04-16 Parvovirus porcino. MX383506B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14165255 2014-04-17
PCT/EP2015/058221 WO2015158798A1 (en) 2014-04-17 2015-04-16 Porcine parvovirus

Publications (2)

Publication Number Publication Date
MX2016013584A true MX2016013584A (es) 2017-01-26
MX383506B MX383506B (es) 2025-03-14

Family

ID=50513094

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013584A MX383506B (es) 2014-04-17 2015-04-16 Parvovirus porcino.

Country Status (11)

Country Link
US (1) US10398773B2 (es)
EP (1) EP3132026B1 (es)
JP (2) JP6938155B2 (es)
KR (2) KR102392649B1 (es)
CN (1) CN106459928A (es)
BR (1) BR112016023787A2 (es)
CA (1) CA2944865C (es)
ES (1) ES2771850T3 (es)
MX (1) MX383506B (es)
RU (1) RU2016144766A (es)
WO (1) WO2015158798A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
EP3132026B1 (en) * 2014-04-17 2020-01-01 Intervet International B.V. Porcine parvovirus
CN108315401B (zh) * 2018-04-26 2021-08-27 华南农业大学 检测猪链球菌2型、猪多杀性巴氏杆菌和副猪嗜血杆菌的三重pcr引物、方法及试剂盒
CN112996907A (zh) * 2018-11-12 2021-06-18 英特维特国际股份有限公司 新型猪轮状病毒
KR102117811B1 (ko) 2018-12-05 2020-06-02 대한민국(농림축산식품부 농림축산검역본부장) 재조합 돼지파보바이러스 항원 단백질 및 이의 용도
MX2022003068A (es) * 2019-09-16 2022-06-14 Dalu Chen Metodos para bloquear la infeccion por asfv mediante la interrupcion de receptores celulares.
CN115976278B (zh) * 2022-10-18 2025-03-11 杭州海关技术中心 基于maldi-tof质谱检测七种猪呼吸道病毒的pcr引物、探针、试剂盒和方法
CN117866053B (zh) * 2024-01-10 2024-07-02 武汉珈创生物技术股份有限公司 同时检测多种猪细小病毒的多克隆抗体及其制备和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2777692A1 (en) 2009-10-14 2011-04-21 Sanjay Kapil Isolation of a virus related to canine parvovirus-2 from a raccoon
DK2542260T3 (en) 2010-03-05 2016-06-06 Intervet Int Bv Recombinantly weakening parvovirus
CN102965345B (zh) 2012-11-19 2014-04-30 江苏省农业科学院 猪细小病毒、疫苗组合物及其应用
US20140170180A1 (en) * 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
KR102197266B1 (ko) * 2013-03-12 2020-12-31 베링거 인겔하임 애니멀 헬스 유에스에이 인크. 돼지 파르보바이러스 5ａ, 이용 방법 및 백신
CN105263953B (zh) * 2014-01-15 2020-01-07 勃林格殷格翰动物保健美国有限公司 猪细小病毒5a、使用方法及疫苗
EP3132026B1 (en) * 2014-04-17 2020-01-01 Intervet International B.V. Porcine parvovirus

Also Published As

Publication number Publication date
CA2944865C (en) 2022-05-03
WO2015158798A1 (en) 2015-10-22
US10398773B2 (en) 2019-09-03
JP6938155B2 (ja) 2021-09-22
RU2016144766A (ru) 2018-05-18
ES2771850T3 (es) 2020-07-07
EP3132026B1 (en) 2020-01-01
KR102392649B1 (ko) 2022-04-28
BR112016023787A2 (pt) 2017-10-17
KR20210123413A (ko) 2021-10-13
RU2020111219A (ru) 2020-07-08
CA2944865A1 (en) 2015-10-22
MX383506B (es) 2025-03-14
KR20160144383A (ko) 2016-12-16
CN106459928A (zh) 2017-02-22
JP2017517248A (ja) 2017-06-29
JP2020167992A (ja) 2020-10-15
EP3132026A1 (en) 2017-02-22
RU2016144766A3 (es) 2018-10-01
US20170056492A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
MX2016013584A (es) Parvovirus porcino.
MX378905B (es) Pestivirus.
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
TWI799368B (zh) 抗ｔｌ１ａ抗原結合蛋白及相關核酸、表現載體、宿主細胞、醫藥組合物、方法及用途
MX2018002106A (es) Vacunas terapeuticas contra el hpv18.
MX384795B (es) Vectores que comprenden secuencias de polinucleotidos rellenadoras/de relleno y metodos de uso.
MX2022003704A (es) Anticuerpos anti-huntingtina (htt) derivados de humano y usos de los mismos.
MX2017005774A (es) Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
EA201692394A1 (ru) Антитела и антигенсвязывающие фрагменты, которые специфично связываются с белком тау, ассоциированным с микротрубочками
MY181175A (en) Therapeutic hpv16 vaccines
MX387400B (es) Células de mamífero que expresan antígenos de citomegalovirus.
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
WO2016106458A8 (es) Virus aav/xbp1s-ha, método de tratamiento genético y su uso en la optimización y mejoramiento de las capacidades cognitivas, de memoria y de aprendizaje
SG10201807572PA (en) Robust antibody purification
MY179251A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
MX2024000004A (es) Proteinas de fusion de inhibidor de tripsina urinaria (uti).
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
NZ731491A (en) Cd83 binding proteins and uses thereof
HK1244534A1 (zh) 重组疏螺旋体蛋白及其使用方法
WO2013138259A3 (en) Polypeptides for treating and/or limiting influenza infection
CR20210289A (es) NUEVOS PÉPTIDOS Y NUEVA COMBINACIÓN DE PÉPTIDOS PARA EL USO EN LA INMUNOTERAPIA CONTRA EL CARCINOMA HEPATOCELULAR (CHC) Y OTROS TIPOS DE CÁNCER (Divisional 2017-282)
MX2016012986A (es) Composiciones y metodos para identificar especies de ehrlichia.
NZ728041A (en) Substances and methods for the use in prevention and/or treatment in huntington’s disease
HK1208502A1 (en) Improved safety testing